Merck readies Tredaptive for int'l assault

Merck is prepping for the international launch of its cholesterol remedy Tredaptive later this year, with plans to market the drug in Mexico, the U.K. and Germany by the third quarter. Merck release

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.